CLINICAL TRIALS PROFILE FOR REVATIO
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
All Clinical Trials for Revatio
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00359736 ↗ | Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis | Completed | VA Office of Research and Development | Phase 2 | 2006-07-01 | Medicines that decrease blood pressure in the lungs may help idiopathic pulmonary fibrosis (IPF) patients function better. This study will test whether sildenafil improves the ability to exercise in patients with pulmonary fibrosis of unknown cause. |
| NCT00452218 ↗ | Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) | Completed | Bayer | Phase 1 | 2007-03-01 | The purpose of this study is to assess the safety and tolerability of sorafenib in patients with PAH already on existing therapy with a prostacyclin [epoprostenol (Flolan)], treprostinil (Remodulin), or iloprost alone, or with or without sildenafil (Viagra/Revatio). |
| NCT00452218 ↗ | Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH) | Completed | University of Chicago | Phase 1 | 2007-03-01 | The purpose of this study is to assess the safety and tolerability of sorafenib in patients with PAH already on existing therapy with a prostacyclin [epoprostenol (Flolan)], treprostinil (Remodulin), or iloprost alone, or with or without sildenafil (Viagra/Revatio). |
| NCT00507819 ↗ | Sildenafil After the Fontan Operation | Completed | The Mark H. and Blanche M. Harrington Foundation | Phase 2 | 2007-12-01 | In this study, the investigators will evaluate the effect of sildenafil on exercise tolerance in patients with a single cardiac ventricle who have undergone the Fontan operation. The investigators will also evaluate echocardiographic measures of ventricular function and measure quality of life changes using two validated quality of life measures. The hypothesis is that sildenafil will result in increased exercise tolerance in patients who have had the Fontan operation as compared to placebo. |
| NCT00507819 ↗ | Sildenafil After the Fontan Operation | Completed | Children's Hospital of Philadelphia | Phase 2 | 2007-12-01 | In this study, the investigators will evaluate the effect of sildenafil on exercise tolerance in patients with a single cardiac ventricle who have undergone the Fontan operation. The investigators will also evaluate echocardiographic measures of ventricular function and measure quality of life changes using two validated quality of life measures. The hypothesis is that sildenafil will result in increased exercise tolerance in patients who have had the Fontan operation as compared to placebo. |
| NCT00517933 ↗ | Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 2007-08-01 | Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that affects an individual's ability to breathe. This study will evaluate the effectiveness of sildenafil, a medication that increases blood flow to the lungs, at improving breathing function, exercise capacity, and quality of life in people with advanced IPF. |
| NCT00517933 ↗ | Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis | Completed | Pfizer | Phase 3 | 2007-08-01 | Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that affects an individual's ability to breathe. This study will evaluate the effectiveness of sildenafil, a medication that increases blood flow to the lungs, at improving breathing function, exercise capacity, and quality of life in people with advanced IPF. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Revatio
Condition Name
Clinical Trial Locations for Revatio
Trials by Country
Clinical Trial Progress for Revatio
Clinical Trial Phase
Clinical Trial Sponsors for Revatio
Sponsor Name
